- Email: [email protected]
Addenda
AJG – September, 2001
Third Annual Esophagology for Clinicians: Barrett Esophagus and Adenocarcinoma— Management Strategies From Reflux to Resection December 6 – 8, 2001 Disney’s BoardWalk Resort, Disney World Orlando, Florida Included are workshops on new endoscopic therapies for GERD. Course Director: H. Worth Boyce, M.D. Jointly sponsored by the University of South Florida College of Medicine and the Joy McCann Culverhouse Center for Swallowing Disorders. For information, contact: USF Office of Continuing Professional Education. Phone: 813-9744296/800-852-5362; fax: 813-974-3217; website: www. cment.med.usf.edu
American Motility Society Course on Gastrointestinal Motility in Clinical Practice January 18 –20, 2002 Charleston Place Hotel Charleston, South Carolina Sponsored by the American Motility Society, The American Gastroenterological Association, and University of Kansas Medical Center Continuing Education. Participants will receive updates on the current indications, methodology, and interpretation of clinical GI motility tests, with comprehensive discussion on the treatment of Gi motility and functional bowel disorders. Contact: (toll free) 877-404-5823; website: www.kuce.org
ACG Applications for Membership (Including Trainee Membership) If you are interested in becoming an active member or trainee member, applications are available from the American College of Gastroenterology, 4900 South 31st Street, Arlington, VA 22206-1656.
Announcements
2809
Trainee Announcements The American Journal of Gastroenterology has decided to list (presently free of charge) in its Announcement Section trainee candidate availability for trainee gastroenterologists. Trainee candidate listing should include a name, position desired, area of the country desired, and contact address.
ADDENDA Re: Progress in Treatment for Crohn’s Disease, an Editorial, published in the March, 2001 issue on pages 626 – 627. The author acknowledges that the cited work of 1977 demonstrating the efficacy of 6-mercaptopurine in Crohn’s disease (Ref. 2) was performed at Lenox Hill Hospital (New York, NY), with Dr. Burton Korelitz as a primary investigator, and at Mount Sinai Hospital (New York, NY), where Dr. D. Present was the primary investigator. Re: Obesity and Female Gender Increase Breath Ethanol Concentration: Potential Implications for the Pathogenesis of Nonalcoholic Steatohepatitis, an Orginal Contribution, published in the April, 2001 issue on pages 1200 –1204. The third author’s name should appear as T. H. Risby. Citation of grant support for K. Cope: training grant T32 ES 07141. Citation of grant support for T. H. Risby: 1) United States Air Force F 49620-98-1-0403 and 2) NHLBI HL 56091. Re: Management of Heartburn in a Large, Randomized, Community-Based Study: Comparison of Four Therapeutic Strategies, an Original Contribution, published in the June 2001 issue on pages 1704 –1710. A line was deleted from the second sentence of the Methods section of the article’s abstract. The sentence should read: “Subjects received either ranitidine 150 mg b.i.d. for 20 wk, or lansoprazole 30 mg once daily for 20 wk, or ranitidine 150 mg b.i.d. for 8 wk followed by lansoprazole 30 mg once daily for 12 wk (‘step-up’), or lansoprazole 30 mg once daily for 8 wk followed by ranitidine 150 mg b.i.d. for 12 wk (‘stepdown’).”
Third Annual Esophagology for Clinicians: Barrett Esophagus and Adenocarcinoma— Management Strategies From Reflux to Resection December 6 – 8, 2001 Disney’s BoardWalk Resort, Disney World Orlando, Florida Included are workshops on new endoscopic therapies for GERD. Course Director: H. Worth Boyce, M.D. Jointly sponsored by the University of South Florida College of Medicine and the Joy McCann Culverhouse Center for Swallowing Disorders. For information, contact: USF Office of Continuing Professional Education. Phone: 813-9744296/800-852-5362; fax: 813-974-3217; website: www. cment.med.usf.edu
American Motility Society Course on Gastrointestinal Motility in Clinical Practice January 18 –20, 2002 Charleston Place Hotel Charleston, South Carolina Sponsored by the American Motility Society, The American Gastroenterological Association, and University of Kansas Medical Center Continuing Education. Participants will receive updates on the current indications, methodology, and interpretation of clinical GI motility tests, with comprehensive discussion on the treatment of Gi motility and functional bowel disorders. Contact: (toll free) 877-404-5823; website: www.kuce.org
ACG Applications for Membership (Including Trainee Membership) If you are interested in becoming an active member or trainee member, applications are available from the American College of Gastroenterology, 4900 South 31st Street, Arlington, VA 22206-1656.
Announcements
2809
Trainee Announcements The American Journal of Gastroenterology has decided to list (presently free of charge) in its Announcement Section trainee candidate availability for trainee gastroenterologists. Trainee candidate listing should include a name, position desired, area of the country desired, and contact address.
ADDENDA Re: Progress in Treatment for Crohn’s Disease, an Editorial, published in the March, 2001 issue on pages 626 – 627. The author acknowledges that the cited work of 1977 demonstrating the efficacy of 6-mercaptopurine in Crohn’s disease (Ref. 2) was performed at Lenox Hill Hospital (New York, NY), with Dr. Burton Korelitz as a primary investigator, and at Mount Sinai Hospital (New York, NY), where Dr. D. Present was the primary investigator. Re: Obesity and Female Gender Increase Breath Ethanol Concentration: Potential Implications for the Pathogenesis of Nonalcoholic Steatohepatitis, an Orginal Contribution, published in the April, 2001 issue on pages 1200 –1204. The third author’s name should appear as T. H. Risby. Citation of grant support for K. Cope: training grant T32 ES 07141. Citation of grant support for T. H. Risby: 1) United States Air Force F 49620-98-1-0403 and 2) NHLBI HL 56091. Re: Management of Heartburn in a Large, Randomized, Community-Based Study: Comparison of Four Therapeutic Strategies, an Original Contribution, published in the June 2001 issue on pages 1704 –1710. A line was deleted from the second sentence of the Methods section of the article’s abstract. The sentence should read: “Subjects received either ranitidine 150 mg b.i.d. for 20 wk, or lansoprazole 30 mg once daily for 20 wk, or ranitidine 150 mg b.i.d. for 8 wk followed by lansoprazole 30 mg once daily for 12 wk (‘step-up’), or lansoprazole 30 mg once daily for 8 wk followed by ranitidine 150 mg b.i.d. for 12 wk (‘stepdown’).”